LOGIN 

 

JOIN

 

RENEW

2020 Virtual Mini Symposia Schedule

HomeMembersAssemblies and SectionsAbout2020 Virtual Mini Symposia Schedule ▶ PC - D96 & A93 - What's New In PAH And RV Signaling: Lessons From The Best Abstracts
PC - D96 & A93 - What's New In PAH And RV Signaling: Lessons From The Best Abstracts

Date: Wednesday, December 16, 2020

<Back to Mini Symposia Main Page

2020 Program Chair: Sebastian Bonnet, PhD, FAHA
2021 Program Chair: Elena A. Goncharova, PhD
2021 Chair-Elect: Brian B. Graham, MD

Moderated By: Andrea Frump, MS, PhD, Werner Seeger, MD and Soban Umar, MD, PhD

  • SGLT2 Inhibition Ameliorates Exercise-Induced Pulmonary Hypertension (EIPH) in Heart Failure with Preserved Ejection Fraction – Taijyu Satoh, MD, PhD (2:37)

  • Role of PKM2-PARP1/Inflammation/Oxidative DNA Damage Axis in the Pathogenesis of Right Ventricular Failure Associated with Pulmonary Arterial Hypertension – Tsukasa Shimauchi, MD, PhD (12:52)

  • Loss of Estrogen Receptor Alpha (ERα) Worsens Hemodynamic Alterations and Right Ventricular (RV) Adaptation in Female Rats with Pulmonary Hypertension (PH) – Andrea Frump, PhD (25:08)

  • Long Non-Coding RNA H19 Promotes Right Ventricular Failure in PAH – Junichi Omura, MD, PhD (37:04)

  • Litaf-Dependent Pericyte Signaling Perpetuates Vascular Inflammation in Pulmonary Hypertension – David Condon, MD (48:11)

  • Mutation of the Epigenetic Regulatortet2 Is Associated with Increased Inflammation in Pulmonary Arterial Hypertension – Francois Potus, PhD (1:01:00)

  • Y-Chromosome Gene, Uty, Protects Against Pulmonary Hypertension by Reducing Proinflammatory Cytokines and Endothelial Death – Christine Cunningham, BS (1:10:54)

  • Therapeutic Potential of the Nuclear Receptor Modulator SR9011 for Treatment of Pulmonary Hypertension – Roxane Paulin, PhD (1:24:30)

  • Intratracheal Gene Delivery of SIN3A Inhibits Pulmonary Arterial Hypertension and Restores BMPR2 Expression – Malik Bisserier, PhD (1:36:21)

  • Role of Checkpoint Kinases in Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis Wen Wu, PhD (1:44:50)